Hydrochlorothiazide/Moexipril Hydrochloride

氢氯噻嗪/盐酸莫昔普利

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHydrochlorothiazide/Moexipril Hydrochloride
Drug Alias Name盐酸莫昔普利/氢氯噻嗪moexipril HCl / hydrochlorothiazideMoexipril hydrochloride/hydrochlorothiazidemoexipril hydrochloride and hydrochlorothiazideMoexipril hydrochloride - hydrochlorothiazide mixt +[6] 
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsAngiotensin-converting enzyme inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1997/06/27
Country/TerritoryUnited States
CombinationsYes HydrochlorothiazideMoexipril Hydrochloride
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesUcb Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUcb Inc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC09BA13
Related LinksKEGG